Literature DB >> 1700555

Radical and nonradical hepatic resection for alveolar echinococcosis: report of 18 cases.

C Partensky1, R Landraud, P J Valette, P Bret, P Paliard.   

Abstract

The authors report their experience with 18 patients who underwent liver resection for alveolar echinococcosis of the liver from June, 1982 to January, 1989. Preparation for surgery included transhepatic biliary external-internal drainage in order to alleviate jaundice in 8 cases and catheterization of infected necrotic cavities in 7 cases. Resection was radical in 9 patients who underwent either right lobectomy (5 cases) or right trisegmentectomy (4 cases) with "en bloc" extension to the bifurcation of the hepatic ducts in 3 cases. Resection was nonradical in another group of 9 patients who had either atypical right hepatectomy (6 cases) or atypical left hepatectomy (3 cases). All patients were submitted to a periodic follow-up. The 9 patients treated by radical resection are alive and symptom-free and appear to be disease-free at radiologic imaging, except for 1 patient who had a small area of parasitic recurrence on computed tomography scan 4 years after operation. Among the 9 patients treated by palliative resection, 3 patients died during the follow-up period, the cause of the death having been related to the disease in 2 cases and nonrelated in 1 case. The 6 surviving patients had no noticeable growth of the parasitic mass during the period of follow-up. When feasible, radical liver resection is the best form of therapy. When massive parasitic invasion of both lobes of the liver and the porta hepatis and vena cava precludes radical hepatectomy, palliative resection associated with percutaneous procedures has to be considered before embarking on orthotopic liver transplantation.

Entities:  

Mesh:

Year:  1990        PMID: 1700555     DOI: 10.1007/bf01658818

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  [Pulmonary metastasis of alveolar echinococcosis. Frequency and mechanisms of occurrence].

Authors:  S Bresson-Hadni; D Vuitton; D Didier; J P Etievent; G Mantion; J P Miguet; M Gillet
Journal:  Presse Med       Date:  1989-01-21       Impact factor: 1.228

2.  Orthotopic liver transplantation in alveolar echinococcosis of the liver: analysis of a series of six patients.

Authors:  M Gillet; J P Miguet; G Mantion; S Bresson-Hadni; M C Becker; C Rouget; J L Christophe; M Roullier; G Landecy; L Guerder
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

3.  New aspects in the management of alveolar echinococcosis involving the liver.

Authors:  R Schröder; G Robotti
Journal:  World J Surg       Date:  1986-12       Impact factor: 3.352

4.  [Contribution of tomodensitometry to the diagnosis and surveillance of hepatic alveolar echinococcosis].

Authors:  A Lassègue; J P Deschamps; D Vuitton; H Allemand; P Singer; Y Ottignon; P Rohmer; E Birh; F Veillon; A Belloir; G Perriguey; P Carayon; J P Miguet
Journal:  Gastroenterol Clin Biol       Date:  1982-11

5.  Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis.

Authors:  A Davis; Z S Pawlowski; H Dixon
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

6.  Alveolar hydatid disease. A review of clinical features of 33 indigenous cases of Echinococcus multilocularis infection in Alaskan Eskimos.

Authors:  J F Wilson; R L Rausch
Journal:  Am J Trop Med Hyg       Date:  1980-11       Impact factor: 2.345

7.  Computed tomographic diagnosis of Echinococcus alveolaris.

Authors:  W Maier
Journal:  Hepatogastroenterology       Date:  1983-06

8.  [Treatment of cholestasis caused by stenosis of the intrahepatic bile ducts in alveolar echinococcosis. Trial of biliary drainage by the percutaneous transhepatic approach].

Authors:  P M Bret; P Paliard; C Partensky; M Bretagnolle; P Blanchut
Journal:  Gastroenterol Clin Biol       Date:  1984-04

9.  [Treatment of human alveolar echinococcosis with flubendazole. Clinical, morphological and immunological study].

Authors:  A Lassègue; J M Estavoyer; H Minazzi; T Barale; M Gillet; D Vuitton; J P Miguet
Journal:  Gastroenterol Clin Biol       Date:  1984-04

10.  Effect of plasma mebendazole concentrations in the treatment of human echinococcosis.

Authors:  W Woodtli; J Bircher; F Witassek; J Eckert; B Wüthrich; R W Ammann
Journal:  Am J Trop Med Hyg       Date:  1985-07       Impact factor: 2.345

View more
  3 in total

1.  Combined resection of the liver and the inferior vena cava for hydatid disease.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  J Gastrointest Surg       Date:  2007-12       Impact factor: 3.452

Review 2.  Non-surgical and non-chemical attempts to treat echinococcosis: do they work?

Authors:  Francesca Tamarozzi; Lucine Vuitton; Enrico Brunetti; Dominique Angèle Vuitton; Stéphane Koch
Journal:  Parasite       Date:  2014-12-23       Impact factor: 3.000

3.  A new treatment strategy for end-stage hepatic alveolar echinococcosis: IVC resection without reconstruction.

Authors:  Qiancheng Du; Yanyan Wang; Mengzhao Zhang; Yichong Chen; Xuepeng Mei; Yanfei Li; Ying Zhou; Haining Fan
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.